← SynDRA
OLOMOUCINE
SynDRA canonical compound SYN0000753 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | CDK1 |
| Mechanism of action | CDK inhibitor |
All known targets
Mechanisms of action (all sources)
- cyclin-dependent kinase inhibitor
- CDK1 BINDER
- CDK2 INHIBITOR
- CDK5 INHIBITOR
Drug classes
Cross-references
Synonyms
- 4erk
- UNII-6A839B2HYS
- 2-(2-Hydroxyethylamino)-6-benzylamino-9-methylpurine
- 6A839B2HYS
- CHEMBL280074
- 2-{[6-(benzylamino)-9-methyl-9h-purin-2-yl]amino}ethanol
- 6-Benzylamino-2-(2-hydroxyethylamino)-9-methylpurine
- 6-(Benzylamino)-2-(2-hydroxyethylamino)-9-methylpurine
- Ethanol,2-[[9-methyl-6-[(phenylmethyl)amino]-9H-purin-2-yl]amino]-
- OLO
- 2-(Hydroxyethylamino)-6-benzylamino-9-methylpurine
- 6-Benylamino-2-(2-hydroxyethylamino)-9-methylpurine
- Olomucine
- NSC 666096
- 2-(2-Hydroxyethylamino)-6-(benzylamino)-9-methylpurine
- 2-{[6-(benzylamino)-9-methyl-9H-purin-2-yl]amino}ethan-1-ol
- CHEBI:44661
- 2-((6-(benzylamino)-9-methyl-9H-purin-2-yl)amino)ethan-1-ol
- RefChem:856758
- DTXCID8066559
- 2-((6-(Benzylamino)-9-methyl-9H-purin-2-yl)amino)ethanol
- MFCD00189360
- 6-benzylamino-2-[2-hydroxyethylamino]-9-methylpurine
- 2-(2-Hydroxyethylamino)-6-benzylamino-9-isopropylpurine
- SR-01000075518
- 2-[[6-(benzylamino)-9-methylpurin-2-yl]amino]ethanol
- Olomoucine?
- purine deriv. 5
- Kinome_2870
- Tocris-1284
- 1w0x
- BiomolKI_000046
- Lopac-O-0886
- BiomolKI2_000052
- UPCMLD-DP136
- CBiol_002050
- Lopac0_000883
Look up OLOMOUCINE in the interactive SynDRA portal →